Singulair is used to prevent asthma attacks in both adults and children over twelve months of age. A range of effective strategies are used to achieve this goal, focusing on preventing bronchospasm or asthma attacks that can result from physical activity. These measures are applied to both adults and children aged six years or older, to ensure that they are able to safely perform their daily activities.
Singulair treatment includes controlling the symptoms of allergic rhinitis that may appear throughout the year in adults and infants.